Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results

Ciardiello, F; Bang, YJ; Cervantes, A; Dvorkin, M; Lopez, CD; Metges, JP; Ruiz, AS; Calvo, M; Strickland, AH; Kannourakis, G; Muro, K; Kawakami, H; Wei, J; Borg, C; Zhu, ZY; Gupta, N; Pelham, RJ; Shen, L

Shen, L (通讯作者)，Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R China.

CANCER MEDICINE, 2023; 12 (12): 13145

Abstract

BackgroundPoly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are approved for the treatment of various solid tumors. In gastric cancer, genes comm......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索